Mark Shearman

Insider Reports History

Entity
Individual
Location
C/O Applied Genetic Technologies Corp, 11801 Research Drive, Suite D, Alachua, Florida
Signature
/s/ Mark Shearman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Shearman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Editas Medicine, Inc. EVP, CHIEF SCIENTIFIC OFFICER Common Stock 65,559 $714 K $10.90 Feb 13, 2023 Direct

Insider Reports Filed by Mark Shearman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EDIT Editas Medicine, Inc. Feb 13, 2023 1 -26,966 4 Feb 15, 2023 EVP, CHIEF SCIENTIFIC OFFICER
EDIT Editas Medicine, Inc. Jun 15, 2022 1 -51,745 4 Jun 16, 2022 EVP, CHIEF SCIENTIFIC OFFICER
EDIT Editas Medicine, Inc. Feb 10, 2022 2 0 4 Feb 11, 2022 EVP, CHIEF SCIENTIFIC OFFICER
EDIT Editas Medicine, Inc. Dec 22, 2021 1 0 4 Dec 23, 2021 EVP, Chief Scientific Officer
EDIT Editas Medicine, Inc. Jun 14, 2021 2 0 4 Jun 16, 2021 EVP, Chief Scientific Officer
EDIT Editas Medicine, Inc. Jun 14, 2021 0 0 3 Jun 16, 2021 EVP, Chief Scientific Officer